Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CFTR | P13569 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13353027 | 0.96 | KMT2A (0.57) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL14691040 | 0.92 | KMT2A (0.50) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL18810823 | 0.90 | KMT2A (0.51) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL18624215 | 0.89 | KMT2A (0.50) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL30492227 | 0.89 | KMT2A (0.64) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL13066502 | 0.89 | KMT2A (0.64) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL6935168 | 0.86 | TSHR (0.47) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL14691245 | 0.85 | KMT2A (0.47) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL4956421 | 0.84 | KMT2A (0.59) | KMT2ATSHRLMNAALDH1A1CFTR | |
| SCHEMBL18280693 | 0.84 | TDP1 (0.50) | KMT2ATSHRLMNAALDH1A1CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017216299-A1 | EMITTER MOLECULES ON THE BASIS OF DUAL-FLUORESCENCE BENZENE (POLY)CARBOXYLATE ACCEPTORS | Technische Universität Dresden (DE) | 2017-12-21 | — | — | WO | disclosed |
| US-20170125701-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-20170125701-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-9102616-B2 | Organic compound, organic electronic device using same, and terminal for same | DUK SAN NEOLUX CO., LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-9102616-B2 | Organic compound, organic electronic device using same, and terminal for same | DUK SAN NEOLUX CO., LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-20130065318-A1 | DETECTION OF ANALYTES INCLUDING NITRO-CONTAINING ANALYTES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-03-14 | — | — | US | disclosed |
| US-8384068-B2 | Use of acridine derivatives as matrix materials and/or electron blockers in OLEDs | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| EP-2195868-B1 | USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS | BASF SE (DE) | 2013-01-02 | — | — | EP | disclosed |
| US-20120217492-A1 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-08-30 | — | — | US | disclosed |
| US-20120217492-A1 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-08-30 | — | — | US | disclosed |
| US-20100219406-A1 | USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR ELECTRON BLOCKERS IN OLEDS | BASF SE (DE) | 2010-09-02 | — | — | US | disclosed |
| EP-2195868-A1 | USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS | Basf Se (DE) | 2010-06-16 | — | — | EP | disclosed |
| WO-2009047147-A1 | USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS | BASF SE (DE) | 2009-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120217492-A1 | ORGANIC COMPOUND, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL FOR SAME | OR10J3, OR51E2, ORC3 | KMT2A 859/4885TSHR 3493/4885LMNA 4394/4885 |
| US-20170125701-A1 | MATERIALS FOR ELECTRONIC DEVICES | HCN2, EFNA1, EED | KMT2A 1344/4885TSHR 3625/4885LMNA 3507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.